Drugs in the Pipeline January 2023 Recap: Drug Pipeline Updates By Brian Park, PharmD Publish Date February 1, 2023
News Beta Blocker Use Tied to Reductions in Violence By Diana Ernst, RPh Publish Date January 31, 2023
Drugs in the Pipeline Gepirone Under Review for Major Depressive Disorder By Steve Duffy Publish Date January 25, 2023
News ACP Updates Clinical Guidelines for Major Depressive Disorder Treatment By Diana Ernst, RPh Publish Date January 24, 2023
News Feds to Investigate Overuse of Antipsychotic Drugs by Nursing Homes Publish Date January 19, 2023
News Rykindo Approved for Schizophrenia, Bipolar Disorder By Brian Park, PharmD Publish Date January 17, 2023
Drugs in the Pipeline December 2022 Recap: Drug Pipeline Updates By Brian Park, PharmD Publish Date January 11, 2023
Drugs in the Pipeline Brexpiprazole Gets Priority Review for Agitation With Alzheimer Dementia By Brian Park, PharmD Publish Date January 9, 2023
Drugs in the Pipeline Phase 3 Trial Evaluating MDMA-Assisted Therapy for PTSD Meets Endpoints By Brian Park, PharmD Publish Date January 5, 2023
Drugs in the Pipeline Iloperidone Benefits Patients With Bipolar I Disorder in Phase 3 Trial By Brian Park, PharmD Publish Date December 19, 2022
Drugs in the Pipeline Vraylar Approved as Adjunctive Therapy for Major Depressive Disorder By Diana Ernst, RPh Publish Date December 19, 2022
Drugs in the Pipeline Intranasal Therapy for Major Depressive Disorder Gets Fast Track Status By Brian Park, PharmD Publish Date December 6, 2022
Features Who Is Liable When Patient Fails to Get Required Blood Work Done? By Ann W. Latner, JD Publish Date December 5, 2022
News AAP Releases “Choosing Wisely” Recommendations for Pediatric Emergency Medicine By Diana Ernst, RPh Publish Date December 2, 2022